Literature DB >> 8187324

Do T cells cause HTLV-1-associated disease?: a taxing problem.

S Daenke, C R Bangham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8187324      PMCID： PMC1534872          DOI： 10.1111/j.1365-2249.1994.tb06538.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  20 in total

Review 1.  Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulation.

Authors:  J Yodoi; T Uchiyama
Journal:  Immunol Today       Date:  1992-10

2.  Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.

Authors:  R E Phillips; S Rowland-Jones; D F Nixon; F M Gotch; J P Edwards; A O Ogunlesi; J G Elvin; J A Rothbard; C R Bangham; C R Rizza
Journal:  Nature       Date:  1991-12-12       Impact factor: 49.962

3.  Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation.

Authors:  A Althage; B Odermatt; D Moskophidis; T Kündig; U Hoffman-Rohrer; H Hengartner; R M Zinkernagel
Journal:  Eur J Immunol       Date:  1992-07       Impact factor: 5.532

4.  Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I-associated myelopathy.

Authors:  J Kira; Y Itoyama; Y Koyanagi; J Tateishi; M Kishikawa; S Akizuki; I Kobayashi; N Toki; K Sueishi; H Sato
Journal:  Ann Neurol       Date:  1992-01       Impact factor: 10.422

5.  Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I.

Authors:  Y Iwakura; M Tosu; E Yoshida; M Takiguchi; K Sato; I Kitajima; K Nishioka; K Yamamoto; T Takeda; M Hatanaka
Journal:  Science       Date:  1991-08-30       Impact factor: 47.728

6.  Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis.

Authors:  C E Parker; S Daenke; S Nightingale; C R Bangham
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

7.  Infiltration of helper/inducer T lymphocytes heralds central nervous system damage in human T-cell leukemia virus infection.

Authors:  Y Iwasaki; Y Ohara; I Kobayashi; S Akizuki
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

8.  Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers.

Authors:  Z N Berneman; R B Gartenhaus; M S Reitz; W A Blattner; A Manns; B Hanchard; O Ikehara; R C Gallo; M E Klotman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

9.  HTLV-1 antibody class and subclass distribution in African TSP and control populations.

Authors:  M Verdier; J Bonis; G Leonard; M Dumas; F Denis
Journal:  J Neuroimmunol       Date:  1993-01       Impact factor: 3.478

10.  High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease.

Authors:  I Elovaara; S Koenig; A Y Brewah; R M Woods; T Lehky; S Jacobson
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307
View more
  10 in total

Review 1.  HTLV-1 infections.

Authors:  C R Bangham
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

2.  HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy.

Authors:  K J Jeffery; K Usuku; S E Hall; W Matsumoto; G P Taylor; J Procter; M Bunce; G S Ogg; K I Welsh; J N Weber; A L Lloyd; M A Nowak; M Nagai; D Kodama; S Izumo; M Osame; C R Bangham
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 3.  Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I.

Authors:  C R Bangham; S E Hall; K J Jeffery; A M Vine; A Witkover; M A Nowak; D Wodarz; K Usuku; M Osame
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

Review 4.  Pathogenesis and treatment of HTLV-I associated myelopathy.

Authors:  G P Taylor
Journal:  Sex Transm Infect       Date:  1998-10       Impact factor: 3.519

5.  Induction of tumor necrosis factor alpha in human neuronal cells by extracellular human T-cell lymphotropic virus type 1 Tax.

Authors:  E P Cowan; R K Alexander; S Daniel; F Kashanchi; J N Brady
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

Review 6.  Human T-lymphotropic virus type 1 (HTLV-1): persistence and immune control.

Authors:  Charles R M Bangham
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

7.  High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease.

Authors:  Peter K C Goon; Tadahiko Igakura; Emmanuel Hanon; Angelina J Mosley; Becca Asquith; Keith G Gould; Graham P Taylor; Jonathan N Weber; Charles R M Bangham
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

8.  Induction of pro-inflammatory cytokines by human T-cell leukemia virus type-1 Tax protein as determined by multiplexed cytokine protein array analyses of human dendritic cells.

Authors:  Jaya Ahuja; Veronique Lepoutre; Brian Wigdahl; Zafar K Khan; Pooja Jain
Journal:  Biomed Pharmacother       Date:  2007-03-07       Impact factor: 6.529

9.  Increased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.

Authors:  Mineki Saito; Reiko Tanaka; Shiho Arishima; Toshio Matsuzaki; Satoshi Ishihara; Takashi Tokashiki; Yusuke Ohya; Hiroshi Takashima; Fujio Umehara; Shuji Izumo; Yuetsu Tanaka
Journal:  Retrovirology       Date:  2013-05-07       Impact factor: 4.602

10.  Chitotriosidase 1 in the cerebrospinal fluid as a putative biomarker for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) progression.

Authors:  Yago Côrtes Pinheiro Gomes; Nicole Lardini Freitas; Flávia Santos Souza; Vanessa Sandim; Denise Abreu Pereira; Fábio César Sousa Nogueira; Juliana Echevarria-Lima; Ana Claudia Celestino Bezerra Leite; Marco Antonio Sales Dantas Lima; Marcus Tulius Teixeira Silva; Abelardo Queiroz Campos Araújo; Ana Carolina Paulo Vicente; Otávio Melo Espíndola
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.